Cargando…
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
The prevalence of Hepatitis C Virus (HCV) infection is significantly higher in patients with end-stage renal disease compared to the general population and poses important clinical challenges in patients who undergo kidney transplantation. Historically, interferon-based treatment options have been l...
Autores principales: | Lin, Ming V., Sise, Meghan E., Pavlakis, Martha, Amundsen, Beth M., Chute, Donald, Rutherford, Anna E., Chung, Raymond T., Curry, Michael P., Hanifi, Jasmine M., Gabardi, Steve, Chandraker, Anil, Heher, Eliot C., Elias, Nahel, Riella, Leonardo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945034/ https://www.ncbi.nlm.nih.gov/pubmed/27415632 http://dx.doi.org/10.1371/journal.pone.0158431 |
Ejemplares similares
-
Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation
por: Sise, Meghan E., et al.
Publicado: (2020) -
Long-term Outcome Reporting in Older Kidney Transplant Recipients and the Limitations of Conventional Survival Metrics
por: Vanhove, Thomas, et al.
Publicado: (2022) -
Immunologic monitoring in kidney transplant recipients
por: Townamchai, Natavudh, et al.
Publicado: (2013) -
Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch
por: Yamamoto, Takayuki, et al.
Publicado: (2022) -
Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus
por: Sise, Meghan E., et al.
Publicado: (2020)